Advances in candidiasis in chronic obstructive pulmonary disease

doi:10.19983/j.issn.2096-8493.20210162

Abstract

Abstract:

Candida species, one of the most common opportunistic pathogens, is the leading cause of invasive fungal diseases. Risk factors, such as ageing, comorbidity, dystrophia, immunocompromised, mechanical ventilation, using of broad-spectrum antibiotics or glucocorticoids and candida colonization, contribute to candidiasis in chronic obstructive pulmonary disease (COPD) patients, which is commonly in respiratory tract, also involves oropharyngeal or digestive tract infection. We reviewed and summarized the literatures of risk factors of candidiasis in COPD patients, aimed to deepen the understanding of the disease and further guide clinical diagnosis and treatment.

Key words: Pulmonary disease,chronic obstructive, Candidiasis, Comorbidity, Risk factors

CLC Number:

R563
R519.3

LI He-rui, LUO Li-juan, ZENG Zi-hang, CHEN Yan. Advances in candidiasis in chronic obstructive pulmonary disease[J]. Journal of Tuberculosis and Lung Disease , 2022, 3(1): 44-49. doi: 10.19983/j.issn.2096-8493.20210162

References 64

[1]	Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J, 2019, 53(5):1900164. doi: 10.1183/13993003.00164-2019. doi: 10.1183/13993003.00164-2019 URL
[2]	Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. doi: 10.1016/S0140-6736(18)30841-9 URL
[3]	Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly, 2016, 146:w14281. doi: 10.4414/smw.2016.14281. doi: 10.4414/smw.2016.14281
[4]	Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med, 2015, 373(15):1445-1456. doi: 10.1056/NEJMra1315399. doi: 10.1056/NEJMra1315399 URL
[5]	Pappas PG, Lionakis MS, Arendrup MC, et al. Invasive candidiasis. Nat Rev Dis Primers, 2018, 4:18026. doi: 10.1038/nrdp.2018.26. doi: 10.1038/nrdp.2018.26 pmid: 29749387
[6]	Xiao M, Sun ZY, Kang M, et al. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study. J Clin Microbiol, 2018, 56(7):e00577-18. doi: 10.1128/JCM.00577-18. doi: 10.1128/JCM.00577-18
[7]	廖小雯, 陈玉梅, 汤玉蓉, 等. COPD患者并发真菌感染的临床特点、危险因素及治疗效果分析. 中国病原生物学杂志, 2019, 14(4):452-455. doi: 10.13350/j.cjpb.190417. doi: 10.13350/j.cjpb.190417
[8]	王熊飞, 荣阳. 慢性阻塞性肺疾病并发真菌感染的临床分析与前瞻性研究. 中国医药指南, 2018, 16(4):76-77.
[9]	Sethi S. Infection as a comorbidity of COPD. Eur Respir J, 2010, 35(6):1209-1215. doi: 10.1183/09031936.00081409. doi: 10.1183/09031936.00081409 pmid: 20513910
[10]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031. doi: 10.3760/cma.j.cn112147-20210109-00031
[11]	齐红松. 慢性阻塞性肺疾病急性加重期病原菌特点及其与肺功能的关系. 郑州:郑州大学, 2014.
[12]	张明义. 不同肺功能等级AECOPD患者的病原菌分布特点分析. 现代医学, 2017, 45(3):373-377. doi: 10.3969/j.issn.1671-7562.2017.03.012. doi: 10.3969/j.issn.1671-7562.2017.03.012
[13]	汪群, 张蔷, 黄静, 等. 急性期慢性阻塞性肺疾病真菌感染高危因素分析及疗效观察. 中国真菌学杂志, 2018, 13(1):15-19. doi: 10.3969/j.issn.1673-3827.2018.01.005. doi: 10.3969/j.issn.1673-3827.2018.01.005
[14]	石少敏, 李立, 王静. 慢性阻塞性肺疾病急性发作期继发真菌感染83例临床分析. 中国老年学杂志, 2010, 30(20):2919-2921.
[15]	Tukenmez Tigen E, Bilgin H, Perk Gurun H, et al. Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey. Am J Infect Control, 2017, 45(6):e61-e63. doi: 10.1016/j.ajic.2017.02.022. doi: 10.1016/j.ajic.2017.02.022 URL
[16]	范彬, 邓旭亮, 冯海兰, 等. 中老年患者口腔念珠菌携带情况的研究. 北京口腔医学, 2012, 20(1):33-36. doi: 10.3969/j.issn.1006-673X.2012.01.010. doi: 10.3969/j.issn.1006-673X.2012.01.010
[17]	张雪燕. 慢性阻塞性肺疾病患者外周血T淋巴细胞亚群水平与合并肺部真菌感染的相关性研究. 唐山:华北理工大学, 2020.
[18]	金春杰, 韩成勋. 慢性阻塞性肺病(慢阻肺)合并肺部真菌感染患者免疫功能的变化及其意义. 世界最新医学信息文摘, 2019, 19(15):53-54. doi: 10.19613/j.cnki.1671-3141.2019.15.028. doi: 10.19613/j.cnki.1671-3141.2019.15.028
[19]	张黎, 蒋艳秋, 黄燕, 等. 慢性阻塞性肺疾病肺部侵袭性真菌感染危险因素及细胞因子基因多态性. 中华医院感染学杂志, 2021, 31(13):1930-1935. doi: 10.11816/cn.ni.2021-202878. doi: 10.11816/cn.ni.2021-202878
[20]	Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr, 2010, 29(2):154-159. doi: 10.1016/j.clnu.2009.12.004. doi: 10.1016/j.clnu.2009.12.004 pmid: 20060626
[21]	赵京梅, 王永红, 李国翔, 等. 对住院慢阻肺患者营养风险临床调查分析. 临床肺科杂志, 2018, 23(6):1098-1100. doi: 10.3969/j.issn.1009-6663.2018.06.032. doi: 10.3969/j.issn.1009-6663.2018.06.032
[22]	纵单单, 诸兰艳, 陈平. COPD 合并肺真菌感染危险因素及伊曲康唑的临床疗效. 中国感染控制杂志, 2015, 14(4):227-231. doi: 10.3969/j.issn.1671-9638.2015.04.04. doi: 10.3969/j.issn.1671-9638.2015.04.04
[23]	江苏安, 严建平, 陈方方. COPD继发肺部真菌感染的临床特征及发病相关因素分析. 中华医院感染学杂志, 2017, 27(1):105-108. doi: 10.11816/cn.ni.2017-162602. doi: 10.11816/cn.ni.2017-162602
[24]	李建民, 崔涛, 宋翠云. COPD患者肺部真菌感染的危险因素分析. 临床医学研究与实践, 2018, 3(27):120-121. doi: 10.19347/j.cnki.2096-1413.201827052. doi: 10.19347/j.cnki.2096-1413.201827052
[25]	温伟杰. COPD患者肺部真菌感染菌株分布及相关危险因素分析. 临床合理用药, 2018, 11(1A):142-143. doi: 10.15887/j.cnki.13-1389/r.2018.01.080. doi: 10.15887/j.cnki.13-1389/r.2018.01.080
[26]	陈辅萍. 慢性阻塞性肺疾病并发感染性肺炎危险因素分析. 陕西医学杂志, 2020, 49(1):102-104. doi: 10.3969/j.issn.1000-7377.2020.01.028. doi: 10.3969/j.issn.1000-7377.2020.01.028
[27]	洪永设. 老年COPD急性加重合并Ⅱ型呼吸衰竭患者肺部真菌感染相关因素的Logistic回归分析. 医学理论与实践, 2021, 34(1):50-52. doi: 10.19381/j.issn.1001-7585.2021.01.020. doi: 10.19381/j.issn.1001-7585.2021.01.020
[28]	Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med, 2014, 40(10):1429-1448. doi: 10.1007/s00134-014-3355-z. doi: 10.1007/s00134-014-3355-z URL
[29]	中华医学会重症医学分会. 重症患者侵袭性真菌感染诊断与治疗指南(2007). 中华内科杂志, 2007, 46(11):960-966.
[30]	Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med, 2005, 31(3):393-400. doi: 10.1007/s00134-005-2571-y. doi: 10.1007/s00134-005-2571-y URL
[31]	Magill SS, Swoboda SM, Johnson EA, et al. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis, 2006, 55(4):293-301. doi: 10.1016/j.diagmicrobio.2006.03.013. doi: 10.1016/j.diagmicrobio.2006.03.013 URL
[32]	Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol, 2010, 8(5):340-349. doi: 10.1038/nrmicro2313. doi: 10.1038/nrmicro2313 URL
[33]	Azoulay E, Timsit JF, Tafflet M, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest, 2006, 129(1):110-117. doi: 10.1378/chest.129.1.110. doi: 10.1378/chest.129.1.110 pmid: 16424420
[34]	Hamet M, Pavon A, Dalle F, et al. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med, 2012, 38(8):1272-1279. doi: 10.1007/s00134-012-2584-2. doi: 10.1007/s00134-012-2584-2 pmid: 22699790
[35]	时永红, 毕淑敏, 张春梅. 老年慢性阻塞性肺疾病患者肺部真菌感染的危险因素分析. 中华医院感染学杂志, 2013, 23(15):3810-3812.
[36]	王玮琴. 慢性阻塞性肺疾病患者下呼吸道标本检出念珠菌临床意义的研究. 上海:上海交通大学, 2020.
[37]	Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol, 2007, 98(3):225-238. doi: 10.1016/S1081-1206(10)60711-9. doi: 10.1016/S1081-1206(10)60711-9 URL
[38]	Dekhuijzen PNR, Batsiou M, Bjermer L, et al. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device. Respir Med, 2016, 120:54-63. doi: 10.1016/j.rmed.2016.09.015. doi: S0954-6111(16)30245-1 pmid: 27817816
[39]	Molimard M, Le Gros V, Robinson P, et al. Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting. J Aerosol Med Pulm Drug Deliv, 2010, 23(2):91-95. doi: 10.1089/jamp.2009.0762. doi: 10.1089/jamp.2009.0762 URL
[40]	Raj R, Manu MK, Prakash PY, et al. The effect of 6 months or longer duration of chronic obstructive respiratory disease medication on the oral health parameters of adults. Spec Care Dentist, 2018, 38(3):133-138. doi: 10.1111/scd.12282. doi: 10.1111/scd.12282 URL
[41]	Yang M, Chen H, Zhang Y, et al. Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis. Inhal Toxicol, 2017, 29(5):219-226. doi: 10.1080/08958378.2017.1346006. doi: 10.1080/08958378.2017.1346006 URL
[42]	中华医学会“念珠菌病诊治策略高峰论坛”专家组. 念珠菌病诊断与治疗:专家共识. 中国感染与化疗杂志, 2011, 11(2):81-95. doi: 10.16718/j.1009-7708.2011.02.009. doi: 10.16718/j.1009-7708.2011.02.009
[43]	施毅, 刘又宁, 张波, 等. 肺念珠菌病. 中国感染与化疗杂志, 2011, 11(2):114-118. doi: 10.16718/j.1009-7708.2011.02.020. doi: 10.16718/j.1009-7708.2011.02.020
[44]	中国成人念珠菌病诊断与治疗专家共识组. 中国成人念珠菌病诊断与治疗专家共识. 中国医学前沿杂志(电子版), 2020, 12(1):35-50. doi: 10.12037/YXQY.2020.01-06. doi: 10.12037/YXQY.2020.01-06
[45]	Zuo YH, Wang WQ, Chen QJ, et al. Candida in Lower Respiratory Tract Increases the Frequency of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Case-Control Study. Front Cell Infect Microbiol, 2020, 10:538005. doi: 10.3389/fcimb.2020.538005. doi: 10.3389/fcimb.2020.538005 URL
[46]	刘又宁. 肺念珠菌感染真的很少见吗? 中华结核和呼吸杂志, 2011, 34(2):81-82. doi: 10.3760/cma.j.issn.1001-0939.2011.02.001. doi: 10.3760/cma.j.issn.1001-0939.2011.02.001
[47]	吴竞, 许岩, 方咏梅, 等. 荧光染色联合1,3-β-D葡聚糖检测对慢性阻塞性肺疾病并发真菌感染的诊断价值. 结核与肺部疾病杂志, 2020, 1(3):140-143. doi: 10.3969/j.issn.2096-8493.2020.02.010. doi: 10.3969/j.issn.2096-8493.2020.02.010
[48]	Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med, 2021, 27(1):115-124. doi: 10.1038/s41591-020-1105-z. doi: 10.1038/s41591-020-1105-z URL
[49]	Weerasuriya N, Snape J. A study of candida esophagitis in elderly patients attending a district general hospital in the UK. Dis Esophagus, 2006, 19(3):189-192. doi: 10.1111/j.1442-2050.2006.00563.x. doi: 10.1111/j.1442-2050.2006.00563.x pmid: 16722997
[50]	牛海静, 苏秉忠. 消化道真菌及其相关疾病研究进展. 中国真菌学杂志, 2015, 10(6):377-379, 384.
[51]	杨涛, 奚志钢, 熊锋, 等. 老年AECOPD患者口腔真菌感染早期干预的时机与疗效. 中华急诊医学杂志, 2021, 30(4):422-425. doi: 10.3760/cma.j.issn.1671-0282.2021.04.008. doi: 10.3760/cma.j.issn.1671-0282.2021.04.008
[52]	León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med, 2006, 34(3):730-737. doi: 10.1097/01.CCM.0000202208.37364.7D. doi: 10.1097/01.CCM.0000202208.37364.7D URL
[53]	Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 62(4):e1-50. doi: 10.1093/cid/civ933. doi: 10.1093/cid/civ933 URL
[54]	李培, 苏欣, 施毅. 再谈下呼吸道分离出念珠菌的意义. 中华结核和呼吸杂志, 2014, 37(1):67-69. doi: 10.3760/cma.j.issn.1001-0939.2014.01.024. doi: 10.3760/cma.j.issn.1001-0939.2014.01.024
[55]	Garbino J, Lew DP, Romand JA, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med, 2002, 28(12):1708-1717. doi: 10.1007/s00134-002-1540-y. doi: 10.1007/s00134-002-1540-y URL
[56]	Nseir S, Jozefowicz E, Cavestri B, et al. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med, 2007, 33(1):137-142. doi: 10.1007/s00134-006-0422-0. doi: 10.1007/s00134-006-0422-0 URL
[57]	张舸, 冯彬彬, 陆志华, 等. 机械通气患者下呼吸道念珠菌去定植治疗对预后的影响. 中华医学杂志, 2017, 97(28):2198-2201. doi: 10.3760/cma.j.issn.0376-2491.2017.28.008. doi: 10.3760/cma.j.issn.0376-2491.2017.28.008
[58]	Albert M, Williamson D, Muscedere J, et al. Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med, 2014, 40(9):1313-1322. doi: 10.1007/s00134-014-3352-2. doi: 10.1007/s00134-014-3352-2 URL
[59]	De Pascale G, Antonelli M. Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer? Intensive Care Med, 2014, 40(9):1381-1384. doi: 10.1007/s00134-014-3364-y. doi: 10.1007/s00134-014-3364-y URL
[60]	魏雪花. 综合护理干预对高龄慢阻肺患者继发性真菌感染的影响. 现代诊断与治疗, 2016, 27(24):4785-4787. doi: 10.3969/j.issn.1001-8174.2016.24.125. doi: 10.3969/j.issn.1001-8174.2016.24.125
[61]	张玉祺. 优质护理干预对慢阻肺患者心理状态及肺部真菌感染发生的影响. 医学理论与实践, 2020, 33(9):1513-1514. doi: 10.19381/j.issn.1001-7585.2020.09.070. doi: 10.19381/j.issn.1001-7585.2020.09.070
[62]	程挺, 程齐俭, 屠瑾, 等. 基于中国人群吸入激素相关口腔念珠菌病防治的系统评价. 上海交通大学学报(医学版), 2015, 35(11):1607-1612. doi: 10.3969/j.issn.1674-8115.2015.11.003. doi: 10.3969/j.issn.1674-8115.2015.11.003
[63]	钟金树, 陈军红, 王海珍. 慢性阻塞性肺病急性加重期发生真菌感染的危险因素分析及预测指标评价. 中国卫生检验杂志, 2019, 29(21):2669-2672.
[64]	吴映南, 邵伯云. 慢性阻塞性肺病继发真菌性肺炎患者痰培养结果及其发病高危因素分析. 中国微生态学杂志, 2020, 32(2):196-199. doi: 10.13381/j.cnki.cjm.202002016. doi: 10.13381/j.cnki.cjm.202002016